Skip to content

Drug interactions

Dronedarone + Pemigatinib

Severity: Major

Dronedarone and Pemigatinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dronedarone may increase pemigatinib concentrations, worsening hyperphosphatemia, ocular toxicity and other adverse effects. Pemigatinib is a CYP3A4 substrate.

What this interaction means in plain words

Dronedarone and Pemigatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Dronedarone belongs to Cardiovascular; Pemigatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Dronedarone inhibits CYP3A4, reducing pemigatinib clearance.

What to do

Avoid if possible. If necessary, reduce the pemigatinib dose as labeled and monitor phosphate and eyes.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dronedarone and Pemigatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dronedarone with Pemigatinib?

MediHelp rates the interaction as major. Dronedarone and Pemigatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Dronedarone may increase pemigatinib concentrations, worsening hyperphosphatemia, ocular toxicity and other adverse effects. Pemigatinib is a CYP3A4 substrate.

How serious is the interaction between Dronedarone and Pemigatinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible. If necessary, reduce the pemigatinib dose as labeled and monitor phosphate and eyes.

What other medicines interact with Dronedarone?

MediHelp also lists interactions of Dronedarone with, for example, Adagrasib, Amiodarone, Arsenic trioxide. The full list is on the Dronedarone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in